Table 3

Analysis of risk factors of EPS

FactorsBSEWaldP valuesOR95% CI
Age0.030.021.920.1661.030.99 to 1.08
Gender−0.240.171.920.1660.790.56 to 1.11
Age of onset−0.030.021.330.2480.970.93 to 1.02
Typical and atypical antipsychotics polytherapy0.590.362.680.1011.800.89 to 3.66
Atypical antipsychotics polytherapy0.240.191.640.2011.270.88 to 1.84
Taking antipsychotics with high D2 antagonistic ability0.370.174.590.032*1.441.03 to 2.02
Illness duration0.020.0114.490.001**1.021.01 to 1.04
Duration since first prescribed antipsychotics0.020.020.960.3281.020.98 to 1.06
Combined treatments of mood stabiliser0.520.352.180.1401.670.85 to 3.31
Constant−1.3260.14978.84<0.0010.27
  • *p≤0.05; **p≤0.01.

  • EPS, extrapyramidal symptoms.